Latest News and Press Releases
Want to stay updated on the latest news?
-
KING OF PRUSSIA, Pa., June 20, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced its recent participation in the “Cutting Edge Science Meeting Series to End the Opioid Crisis:...
-
KING OF PRUSSIA, Pa., June 02, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will be attending the following investor conferences in June: Jefferies 2017 Global...
-
KING OF PRUSSIA, Pa., May 31, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that the independent Compensation Committee of the Board of Directors of the Company approved,...
-
– Results presented from the successful APOLLO-1 Phase 3 pivotal efficacy study of OLINVOTM (oliceridine injection) in moderate-to-severe acute pain – – New preclinical research highlights the...
-
– Successfully completed two positive Phase 3 pivotal efficacy studies of OLINVO™ (oliceridine injection) –– OLINVO program on track for NDA submission in fourth quarter of 2017 –– Clinical...
-
KING OF PRUSSIA, Pa., April 26, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will be presenting at the 42nd Annual Healthcare Conference hosted by Deutsche Bank...
-
KING OF PRUSSIA, Pa., April 06, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced the first scientific presentation of positive results from two Phase 3 pivotal efficacy studies...
-
KING OF PRUSSIA, Pa., March 29, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will be presenting at Needham & Company’s 16th Annual Healthcare Conference on...
-
KING OF PRUSSIA, Pa., March 14, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will be presenting at the Oppenheimer 27th Annual Healthcare Conference on Tuesday, March...
-
KING OF PRUSSIA, Pa., March 10, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will be presenting at the 2017 Barclays Global Healthcare Conference on Tuesday, March...